pipette
ESEspañol

Tumor-Specific Gene Editing Enhances Cancer Immunogenicity through Succinate Metabolism-Mediated MHC-I Reprogramming

He Yang, Haoyu Zhang, Ziyin Zhao, Yuxuan Ren, Yanhan Xu, Kaimin Cai, Jianjun Cheng, Xun Liu, Yongbing Chen, Lichen Yin

Peer-reviewed journalBold claims, read criticallyReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
Herein, we report a dual tumor-specific CRISPR/Cas9 gene editing system that can precisely knock out succinate dehydrogenase subunit C (Sdhc) to activate the MHC-I pathway via epigenetic and transcriptional regulation.

Appeared: Wednesday, November 4. Journal of the American Chemical Society. Peer-reviewed journal.

DOI: 10.1021/jacs.6c14840